(VHT) Vanguard Health Care Shares - Ratings and Ratios
Pharmaceuticals, Biotechnology, Healthcare, Medical, Equipment
Description: VHT Vanguard Health Care Shares
The Vanguard Health Care Index Fund ETF Shares (VHT) is an exchange-traded fund that tracks the performance of the healthcare sector in the US stock market, covering large, mid-size, and small-cap companies classified under the Global Industry Classification Standard (GICS). By replicating the target index, the fund aims to invest in the constituent stocks in proportion to their weighting, providing broad exposure to the US healthcare sector.
Key performance indicators (KPIs) for VHT include its ability to provide diversified exposure to the healthcare sector, with a portfolio comprising a range of companies across various sub-sectors, such as pharmaceuticals, biotechnology, and healthcare equipment. The funds tracking error, expense ratio, and trading volume are also important metrics to evaluate its performance. With an AUM of $15.34 billion, VHT is a sizable and liquid ETF, making it an attractive option for investors seeking to gain exposure to the US healthcare sector.
From a quantitative perspective, VHTs performance can be evaluated using metrics such as its Sharpe ratio, beta, and alpha relative to its benchmark index. The funds sector allocation, market capitalization distribution, and stock holdings are also important factors to consider when assessing its investment profile. As a passively managed ETF, VHTs low expense ratio and tax efficiency are additional benefits that can contribute to its overall performance.
VHT ETF Overview
| Market Cap in USD | 15,233m |
| Category | Health |
| TER | 0.10% |
| IPO / Inception | 2004-01-26 |
VHT ETF Ratings
| Growth Rating | 0.08% |
| Fundamental | - |
| Dividend Rating | 55.3% |
| Return 12m vs S&P 500 | -24.4% |
| Analyst Rating | - |
VHT Dividends
| Dividend Yield 12m | 1.55% |
| Yield on Cost 5y | 2.10% |
| Annual Growth 5y | 7.36% |
| Payout Consistency | 96.0% |
| Payout Ratio | % |
VHT Growth Ratios
| Growth Correlation 3m | 62.2% |
| Growth Correlation 12m | -75.7% |
| Growth Correlation 5y | 74% |
| CAGR 5y | 4.36% |
| CAGR/Max DD 3y | 0.26 |
| CAGR/Mean DD 3y | 1.03 |
| Sharpe Ratio 12m | -1.11 |
| Alpha | -28.12 |
| Beta | 0.911 |
| Volatility | 12.48% |
| Current Volume | 188.2k |
| Average Volume 20d | 206.4k |
| Stop Loss | 247 (-3%) |
| Signal | -1.00 |
What is the price of VHT shares?
Over the past week, the price has changed by -0.79%, over one month by +0.86%, over three months by +2.43% and over the past year by -10.17%.
Is Vanguard Health Care Shares a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VHT is around 234.91 USD . This means that VHT is currently overvalued and has a potential downside of -7.77%.
Is VHT a buy, sell or hold?
What are the forecasts/targets for the VHT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 264 | 3.6% |
Last update: 2025-09-15 04:46
VHT Fundamental Data Overview
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.66
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 15.23b USD (15.23b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 15.23b)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 15.23b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(15.23b)/V(0.0) * Re(9.37%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 9.37% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for VHT ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle